Optimal Entry Points in US CLO Mezzanine Tranches: A Historical Excess-Return Analysis (Updated)
Volatility creates opportunities. In the CLO mezzanine market, BBB and BB tranches typically display betas greater than one to changes...
If you are an investor and would be interested in trial access, the Basic content is available on a two-week trial once the trial subscription agreement is in place.
Volatility creates opportunities. In the CLO mezzanine market, BBB and BB tranches typically display betas greater than one to changes...
US CLOs’ overall exposure to Medical Solutions Holdings term loans is approximately USD 662.8 million. As of 26 January 2026, 433 US CLO deals, managed by 37 managers, reported an average deal-level exposure of around 63 bps.
US CLOs’ overall exposure to Atlas CC Acquisition Corp TLs is approximately US$ 651 million. As of 26 January 2026, 340 US CLO deals, managed by 19 managers, reported an average deal-level exposure of around 49 bps.
Below are tables presenting the MVOC (AAA-B) and EQ NAV of US BSL CLO deals by vintage, based on asset prices as of January 23, 2026.
EU CLOs’ overall exposure to Sirona Bidco TL is approximately EUR 337.5 million. As of 23 January 2026, 145 EU CLO deals, managed by 20 managers, reported an average deal-level exposure of around 64 bps.
US CLOs’ overall exposure to Accelerated Health Systems TL is approximately USD 292.6 million. As of 23 January 2026, 224 US CLO deals, managed by 24 managers, reported an average deal-level exposure of around 37 bps.
US CLOs’ overall exposure to Mitnick Corporate Purchaser Inc (Veracode) 1st Lien Term Loan is approximately USD 648.6 million. As of 23 January 2026, 438 US CLO deals, managed by 30 managers, reported an average deal-level exposure of around 38 bps.
RRE 18’s headline AAA tranche priced tightly at 123 bps. Even so, at this level it continues to offer reasonable value relative to other recent reset transactions.
What Asset Spread Compression Means for AAA-to-Single-A EU CLO Pricing
US CLOs’ overall exposure to Sitel Worldwide TLs is approximately USD 740.1 million. As of 23 January 2026, 435 US CLO deals, managed by 41 managers, reported an average deal-level exposure of around 57 bps. EU CLOs’ overall exposure to Sitel Worldwide TLs is approximately EUR 424.7 million. As of 23 January 2026, 180 EU CLO deals, managed by 30 managers, reported an average deal-level exposure of around 69 bps.
US CLOs’ overall exposure to Learning Care Group TL is approximately USD 637.8 million. As of 21 January 2026, 637 US CLO deals, managed by 36 managers, reported an average deal-level exposure of around 22 bps.
US CLOs’ overall exposure to SkillSoft 7/21 Cov-Lite is approximately USD 332 million. As of 20 January 2026, 345 US CLO deals, managed by 16 managers, reported an average deal-level exposure of around 25 bps.
This article examines how US CLO AAA tranches may look under various scenarios.
US CLOs’ overall exposure to Multi-Color 10/21 (USD) Cov-Lite TL is approximately USD 431 million. As of 16 January 2026, 297 US CLO deals, managed by 17 managers, reported an average deal-level exposure of around 35 bps.
US CLOs’ overall exposure to the Balcan Innovations term loan is approximately USD 355.4 million. As of 15 January 2026, 308 US CLO deals, managed by 23 managers, reported an average deal-level exposure of around 25 bps.
